Review article
When Anticoagulant Therapy is Not an Option
Darija Baković Kramarić
Full text: croatian pdf 354 Kb
page 81-86
downloads: 0
cite
APA 6th Edition
Baković Kramarić, D. (2024). When Anticoagulant Therapy is Not an Option. Medicus, 33 (1 Tromboembolije), 81-81. Retrieved from https://hrcak.srce.hr/321776
MLA 8th Edition
Baković Kramarić, Darija. "When Anticoagulant Therapy is Not an Option." Medicus, vol. 33, no. 1 Tromboembolije, 2024, pp. 81-81. https://hrcak.srce.hr/321776. Accessed 31 Oct. 2024.
Chicago 17th Edition
Baković Kramarić, Darija. "When Anticoagulant Therapy is Not an Option." Medicus 33, no. 1 Tromboembolije (2024): 81-81. https://hrcak.srce.hr/321776
Harvard
Baković Kramarić, D. (2024). 'When Anticoagulant Therapy is Not an Option', Medicus, 33(1 Tromboembolije), pp. 81-81. Available at: https://hrcak.srce.hr/321776 (Accessed 31 October 2024)
Vancouver
Baković Kramarić D. When Anticoagulant Therapy is Not an Option. Medicus [Internet]. 2024 [cited 2024 October 31];33(1 Tromboembolije):81-81. Available from: https://hrcak.srce.hr/321776
IEEE
D. Baković Kramarić, "When Anticoagulant Therapy is Not an Option", Medicus, vol.33, no. 1 Tromboembolije, pp. 81-81, 2024. [Online]. Available: https://hrcak.srce.hr/321776. [Accessed: 31 October 2024]
Full text: english pdf 354 Kb
page 81-81
downloads: 0
cite
APA 6th Edition
Baković Kramarić, D. (2024). When Anticoagulant Therapy is Not an Option. Medicus, 33 (1 Tromboembolije), 81-81. Retrieved from https://hrcak.srce.hr/321776
MLA 8th Edition
Baković Kramarić, Darija. "When Anticoagulant Therapy is Not an Option." Medicus, vol. 33, no. 1 Tromboembolije, 2024, pp. 81-81. https://hrcak.srce.hr/321776. Accessed 31 Oct. 2024.
Chicago 17th Edition
Baković Kramarić, Darija. "When Anticoagulant Therapy is Not an Option." Medicus 33, no. 1 Tromboembolije (2024): 81-81. https://hrcak.srce.hr/321776
Harvard
Baković Kramarić, D. (2024). 'When Anticoagulant Therapy is Not an Option', Medicus, 33(1 Tromboembolije), pp. 81-81. Available at: https://hrcak.srce.hr/321776 (Accessed 31 October 2024)
Vancouver
Baković Kramarić D. When Anticoagulant Therapy is Not an Option. Medicus [Internet]. 2024 [cited 2024 October 31];33(1 Tromboembolije):81-81. Available from: https://hrcak.srce.hr/321776
IEEE
D. Baković Kramarić, "When Anticoagulant Therapy is Not an Option", Medicus, vol.33, no. 1 Tromboembolije, pp. 81-81, 2024. [Online]. Available: https://hrcak.srce.hr/321776. [Accessed: 31 October 2024]
Abstract
Patients with atrial fibrillation who, despite taking oral anticoagulant therapy (OAT), experience a stroke or systemic embolism (SSE) or develop left atrial thrombus (LAAT) should be considered patients with malignant LAA. Administering a different direct oral anticoagulant (DOAC) is the recommended initial step in malignant LAA treatment, followed by switching to a vitamin K antagonist (VKA), low-molecular-weight heparin, or optimized DOAC dosing, while LAA closure is the final option. Left atrial closure is a worthwhile option in patients with embolic stroke even with OAT and no indication of thrombus on TEE (transesophageal echocardiography) (empty LAA) after thorough diagnostic measures to eliminate other sources of embolism, as well as patients with a high risk of hemorrhage.
Keywords
left atrial thrombosis; left atrial occluder; malignant left atrial; stroke
Hrčak ID:
321776
URI
https://hrcak.srce.hr/321776
Publication date:
24.10.2024.
Article data in other languages:
croatian
Visits: 0
*
